Results 211 to 220 of about 1,522,172 (292)
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Considerations in revision of anterior cruciate ligament reconstruction in the high-level athlete. [PDF]
Hauer TM +4 more
europepmc +1 more source
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.
J. Brożek +9 more
semanticscholar +1 more source
ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein +7 more
wiley +1 more source
Liver dysfunction is associated with early postoperative complications following revision total shoulder arthroplasty. [PDF]
Liu SH +5 more
europepmc +1 more source
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo +9 more
wiley +1 more source
PROMPTa-A multifaceted assessment approach to develop writing skills. [PDF]
Puro V, Nittala NAP, A H.
europepmc +1 more source

